Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, United States of America; Department of Medicine, UC San Diego Medical Center, San Diego, CA, United States of America; Veterans Affairs San Diego Healthcare System, San Diego, CA, United States of America.
Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, United States of America; Department of Medicine, UC San Diego Medical Center, San Diego, CA, United States of America; Veterans Affairs San Diego Healthcare System, San Diego, CA, United States of America.
Prev Med. 2019 Jan;118:332-335. doi: 10.1016/j.ypmed.2018.11.020. Epub 2018 Dec 1.
Screening with FIT or colonoscopy can reduce CRC mortality. In our pragmatic, randomized trial of screening outreach over three years, patients annually received mailed FITs or colonoscopy invitations. We examined screening initiation after each mailing and crossover from the invited to other modality. Eligible patients (50-64 years, ≥1 primary-care visit before randomization, and no history of CRC) received mailed FIT kits (n = 2400) or colonoscopy invitations (n = 2400) from March 2013 through July 2016. Among those invited for colonoscopy, we used multinomial logistic regression to identify factors associated with screening initiation with colonoscopy vs. FIT vs. no screening after the first mailing. Most patients were female (61.8%) and Hispanic (48.9%) or non-Hispanic black (24.0%). Among those invited for FIT, 56.6% (n = 1359) initiated with FIT, whereas 3.3% (n = 78) crossed over to colonoscopy; 151 (15.7%) and 61 (7.7%) initiated with FIT after second and third mailings. Among those invited for colonoscopy, 25.5% (n = 613) initiated with colonoscopy whereas 18.8% (n = 452) crossed over to FIT; 112 (8.4%) and 48 (4.2%) initiated with colonoscopy after second and third mailings. Three or more primary-care visits prior to randomization were associated with initiating with colonoscopy (OR 1.49, 95% CI 1.17-1.91) and crossing over to FIT (OR 1.63, 95% CI 1.19-2.23). Although nearly half of patients initiated screening after the first mailing, few non-responders in either outreach group initiated after a second or third mailing. More patients invited to colonoscopy crossed over to FIT than those assigned to FIT crossed over to colonoscopy.
FIT 或结肠镜检查筛查可降低 CRC 死亡率。在我们为期三年的实用、随机的筛查外展试验中,患者每年都会收到邮寄的 FIT 或结肠镜检查邀请。我们检查了每次邮寄后的筛查启动情况以及从受邀者转为其他方式的情况。符合条件的患者(50-64 岁,随机分组前有 1 次以上初级保健就诊,且无 CRC 病史)从 2013 年 3 月至 2016 年 7 月期间收到邮寄的 FIT 试剂盒(n=2400)或结肠镜检查邀请(n=2400)。在受邀接受结肠镜检查的患者中,我们使用多项逻辑回归来确定与首次邮寄后首次接受结肠镜检查筛查、FIT 筛查或不筛查相关的因素。大多数患者为女性(61.8%)和西班牙裔(48.9%)或非西班牙裔黑人(24.0%)。在受邀接受 FIT 的患者中,56.6%(n=1359)开始接受 FIT,而 3.3%(n=78)转为结肠镜检查;第二次和第三次邮寄后,151(15.7%)和 61(7.7%)开始接受 FIT。在受邀接受结肠镜检查的患者中,25.5%(n=613)开始接受结肠镜检查,而 18.8%(n=452)转为 FIT;第二次和第三次邮寄后,112(8.4%)和 48(4.2%)开始接受结肠镜检查。随机分组前有 3 次或更多次初级保健就诊与开始接受结肠镜检查(OR 1.49,95%CI 1.17-1.91)和转为 FIT(OR 1.63,95%CI 1.19-2.23)相关。尽管近一半的患者在第一次邮寄后开始进行筛查,但在两个外展组中,很少有未回复者在第二次或第三次邮寄后开始进行筛查。邀请接受结肠镜检查的患者中,转为 FIT 的人数多于被分配接受 FIT 的患者转为结肠镜检查的人数。